SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences - Quaterly Results

30 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 2050.20 millions grew by 5.14 % from Rs. 1949.94 millions.The Net Profit of the company slipped to Rs. 79.75 millions from Rs. 200.47 millions, a decline of -60.22% on QoQ basis.A decline of 270.23 millions was observed in the OP in the quarter ended March 2025 from 351.09 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2050.20 1949.94 5.14 8198.06 8066.66 1.63 8198.06 8066.66 1.63
Other Income 3.83 8.81 -56.53 36.15 21.77 66.05 36.15 21.77 66.05
PBIDT 270.23 351.09 -23.03 1386.03 1480.48 -6.38 1386.03 1480.48 -6.38
Interest 84.00 36.47 130.33 231.12 153.60 50.47 231.12 153.60 50.47
PBDT 186.23 314.62 -40.81 1154.91 1326.88 -12.96 1154.91 1326.88 -12.96
Depreciation 78.43 43.42 80.63 210.64 170.17 23.78 210.64 170.17 23.78
PBT 107.80 271.20 -60.25 944.27 1156.71 -18.37 944.27 1156.71 -18.37
TAX 28.05 70.73 -60.34 244.95 295.36 -17.07 244.95 295.36 -17.07
Deferred Tax 25.12 -2.27 -1206.61 57.51 31.65 81.71 57.51 31.65 81.71
PAT 79.75 200.47 -60.22 699.32 861.35 -18.81 699.32 861.35 -18.81
Equity 100.28 100.28 0.00 100.28 100.28 0.00 100.28 100.28 0.00
PBIDTM(%) 13.18 18.01 -26.80 16.91 18.35 -7.88 16.91 18.35 -7.88

Gufic Biosciences Share Price

306.05 4.85 (1.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×